How predictive is the Sino-Nasal Outcome Test (SNOT-22) patient-reported outcome measure regarding elective endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS)?
Background: CRS patients must often decide to either continue with repeated medical therapy options or undergo surgery. In the absence of adequate understanding of the potential outcomes from either option, CRS patients often defer to the physician. This analysis was undertaken to determine if the SNOT-22 has the same predictive value in the U.S. and U.K. populations.
Explore this issue:August 2015
Study design: National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis Prospective observational cohort study of a total of 2,263 patients electing ESS in 87 U.K. hospitals.
Setting: Department of Otolaryngology, Guy’s and St. Thomas’ National Health Service Trust, London, United Kingdom; U.K. National Health Service Trust.